APOMORPHINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Apomorphine Hydrochloride patents expire, and when can generic versions of Apomorphine Hydrochloride launch?
Apomorphine Hydrochloride is a drug marketed by Trupharma and is included in one NDA.
The generic ingredient in APOMORPHINE HYDROCHLORIDE is apomorphine hydrochloride. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the apomorphine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Apomorphine Hydrochloride
A generic version of APOMORPHINE HYDROCHLORIDE was approved as apomorphine hydrochloride by TRUPHARMA on February 23rd, 2022.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for APOMORPHINE HYDROCHLORIDE?
- What are the global sales for APOMORPHINE HYDROCHLORIDE?
- What is Average Wholesale Price for APOMORPHINE HYDROCHLORIDE?
Summary for APOMORPHINE HYDROCHLORIDE
Recent Clinical Trials for APOMORPHINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Alexza Pharmaceuticals, Inc. | Phase 2 |
| DSG | Phase 2 |
| Peachtree BioResearch Solutions | Phase 2 |
Pharmacology for APOMORPHINE HYDROCHLORIDE
| Drug Class | Dopaminergic Agonist |
| Mechanism of Action | Dopamine Agonists |
Medical Subject Heading (MeSH) Categories for APOMORPHINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for APOMORPHINE HYDROCHLORIDE
US Patents and Regulatory Information for APOMORPHINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trupharma | APOMORPHINE HYDROCHLORIDE | apomorphine hydrochloride | INJECTABLE;SUBCUTANEOUS | 212025-001 | Feb 23, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
